- Home
- BBNX vs CLOV Comparison
BBNX vs CLOV Comparison
Compare BBNX & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBNX | CLOV |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | BBNX | CLOV |
|---|---|---|
| Price | $29.39 | $2.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $28.09 | $4.23 |
| AVG Volume (30 Days) | 618.5K | ★ 5.5M |
| Earning Date | 10-28-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $88,570,000.00 | ★ $1,773,564,000.00 |
| Revenue This Year | $52.13 | $41.68 |
| Revenue Next Year | $36.16 | $37.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 67.01 | 32.15 |
| 52 Week Low | $8.89 | $2.12 |
| 52 Week High | $32.71 | $4.87 |
Technical Indicators
Market Signals| Indicator | BBNX | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 47.73 |
| Support Level | $27.87 | $2.41 |
| Resistance Level | $31.51 | $2.72 |
| Average True Range (ATR) | 2.09 | 0.12 |
| MACD | -0.22 | 0.04 |
| Stochastic Oscillator | 47.23 | 74.98 |
Price Performance
Historical ComparisonAbout BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.